HealthcareServices

Artificial Pancreas Device System Market Insights Report: Opportunities and Drivers 2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial pancreas device system market from 2026–2035 with trusted insights from The Business Research Company

How much is the Artificial Pancreas Device System Market valued at in 2026, and what valuation is forecast for 2030?

The artificial pancreas device system market has seen rapid growth in recent years. It is anticipated to increase from $2.06 billion in 2025 to $2.35 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.9%. This historical growth can be attributed to factors such as the rising prevalence of diabetes, the early adoption of insulin pump technologies, the expansion of continuous glucose monitoring usage, advancements in medical sensor accuracy, and an increasing awareness of automated diabetes management.

The artificial pancreas device system market is set for rapid growth in the next few years, with its size projected to reach $3.92 billion by 2030 at a compound annual growth rate (CAGR) of 13.7%. This expansion during the forecast period can be attributed to several factors, including the increasing demand for fully automated glucose regulation, rising investments in digital diabetes care, the broadening scope of remote patient monitoring, a growing emphasis on personalized insulin therapy, and enhanced regulatory support for advanced diabetes devices. Key trends for the forecast period include the increasing adoption of closed-loop glucose control systems, greater integration of CGM with insulin pumps, wider use of predictive algorithms for insulin delivery, the expansion of wearable diabetes management devices, and an enhanced focus on patient-centric automation.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

What Drivers Are Influencing The Growth Of The Artificial Pancreas Device System Market?

The expanding occurrence of pancreatic cancer is anticipated to drive future growth in the artificial pancreas device system market. This type of cancer is a malignant growth developing in the pancreas, an organ situated behind the stomach. Its development is affected by various elements, including lifestyle, genetics, medical conditions, and environmental aspects, in addition to genetic mutations that result in hereditary pancreatitis, potentially causing persistent pancreatic inflammation. An artificial pancreas device system (APDS) is chiefly engineered to assist diabetic patients in regulating their blood sugar levels through automated glucose monitoring and precise insulin delivery. As an illustration, Cancer Australia, a government organization, projected in March 2024 that 4,506 new pancreatic cancer diagnoses were made in 2023, representing a rise from the 3,751 cases documented over the past five years. Consequently, the rising occurrence of pancreatic cancer is fueling the expansion of the artificial pancreas device system market.

How Is The Artificial Pancreas Device System Market Organized Into Various Segments?

The artificial pancreas device system market covered in this report is segmented –

1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems

2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid

3) By End-User: Hospitals, Medical Centers, Other End-Users

Subsegments:

1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems

2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems

3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems

What Trends Are Reshaping The Dynamics Of The Artificial Pancreas Device System Market?

Leading companies in the artificial pancreas device system market are developing automated insulin delivery systems to enhance diabetes management by continuously monitoring blood glucose levels and administering the appropriate amount of insulin. These automated insulin delivery systems are designed to mimic the function of a healthy pancreas, thereby reducing the burden of constant blood sugar monitoring and manual insulin administration for individuals with diabetes. As an illustration, in May 2023, Beta Bionics, a US-based medical equipment manufacturing company, obtained FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, an automated insulin delivery device. This artificial pancreas system is engineered to autonomously determine and deliver insulin doses to control blood glucose levels. It operates as a closed-loop system, automatically adjusting insulin delivery based on the user’s glucose levels as measured by a connected continuous glucose monitor (CGM). The system only requires the user’s body weight and an estimate of meal size to automatically regulate insulin delivery.

Who Are The Prominent Global Companies Shaping The Artificial Pancreas Device System Market Landscape?

Major companies operating in the artificial pancreas device system market are Medtronic plc, Abbott Laboratories, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Roche Diabetes Care, Ypsomed, SOOIL Development, Beta Bionics Inc., Bigfoot Biomedical Inc., Diabeloop SA, Inreda Diabetic B.V., Defymed SAS, DreaMed Diabetes Ltd., Medtrum Technologies Inc., EOFlow Co. Ltd., Cellnovo, Pancreum Inc., Admetsys Corporation, GlucoModicum, MicroTech Medical

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Artificial Pancreas Device System Market?

North America was the largest region in the artificial pancreas device system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Artificial Pancreas Device System Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp

Browse Through More Reports Similar to the Global Artificial Pancreas Device System Market 2026, By The Business Research Company

Hepato Pancreatico Biliary Hpb Surgeries Surgical Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepato-pancreatico-biliary-hpb-surgeries-surgical-devices-global-market-report

Diabetes Care Devices Market 2026

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Gastrointestinal Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795